NASDAQ : UPC

Universe Pharmaceuticals INC — Company profile

Healthcare · Drug Manufacturers - Specialty & Generic · China

Last price 1.49 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.49M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Details

NameUniverse Pharmaceuticals INC
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees216
Founded1998
Ipo Date2021-03-23
CeoGang Lai
CountryChina
ExchangeNASDAQ
Fiscal YearOctober - September
Reporting CurrencyUSD
Ipo Price5.00
IsinKYG9442G1385
CusipG9442G138
Cik1809616
Sic2834
Share ClassClass A Shares

Key executives

NameTitle
Gang LaiChief Executive Officer and Chairman
Lin YangChief Financial Officer and Director
Baochang LiuChief Operating Officer

Contact

Address265 Jingjiu Avenue, Jinggangshan Eco & Tech Dev Zn, Ji'An, 343100, China
Phone86 79 6840 3309
Websitehttps://www.universe-pharmacy.com